Regencell Bioscience Holdings Limited - stock earnings
RGC Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -2.6 million USD | ? USD |
2023Q1 | -1321 USD | ? USD |
2022Q4 | -3.2 million USD | ? USD |
2022Q3 | -1613 USD | -2.3 billion USD |
2022Q2 | -1.9 million USD | ? USD |
2022Q1 | -1.9 million USD | ? USD |
2021Q4 | -1.8 million USD | ? USD |
2021Q3 | -65.2 million USD | -2.3 billion USD |
2017Q4 | 28.9 million USD | 861.6 million USD |
2017Q3 | 11.4 million USD | 716.0 million USD |
2017Q2 | 23.6 million USD | 764.2 million USD |
2017Q1 | 48.4 million USD | 821.2 million USD |
2016Q4 | 53.9 million USD | 812.6 million USD |
2016Q3 | 42.3 million USD | 811.5 million USD |
2016Q2 | 33.5 million USD | 785.9 million USD |
2016Q1 | 40.7 million USD | 787.1 million USD |
2015Q4 | 55.0 million USD | 848.2 million USD |
2015Q3 | 21.9 million USD | 725.0 million USD |
2015Q2 | 53.4 million USD | 862.8 million USD |
2015Q1 | 23.1 million USD | 691.3 million USD |
2014Q4 | 46.3 million USD | 799.1 million USD |
2014Q3 | 26.7 million USD | 693.8 million USD |
2014Q2 | 33.8 million USD | 770.3 million USD |
2014Q1 | -1.2 million USD | 726.9 million USD |
2013Q4 | 24.0 million USD | 739.9 million USD |
2013Q3 | 75.1 million USD | 813.1 million USD |
2013Q2 | 36.1 million USD | 842.3 million USD |
2013Q1 | 22.5 million USD | 642.8 million USD |
2012Q4 | 37.3 million USD | 723.1 million USD |
2012Q3 | 24.0 million USD | 692.9 million USD |
2012Q2 | 37.2 million USD | 723.3 million USD |
2012Q1 | 46.3 million USD | 684.9 million USD |
2011Q4 | 4.1 million USD | 613.9 million USD |
2011Q3 | 25.0 million USD | 743.6 million USD |
2011Q2 | 34.8 million USD | 753.3 million USD |
2011Q1 | -23.6 million USD | 570.9 million USD |
2010Q4 | 13.7 million USD | 661.0 million USD |
2010Q3 | 42.6 million USD | 696.4 million USD |
2010Q2 | 12.6 million USD | 1.4 billion USD |
2010Q1 | 16.0 million USD | 719.0 million USD |
2009Q4 | 35.5 million USD | 765.6 million USD |
2009Q3 | -2.0 million USD | 674.0 million USD |
2009Q2 | 40.0 million USD | 789.0 million USD |
2009Q1 | 21.0 million USD | 665.0 million USD |
2008Q4 | 30.0 million USD | 711.0 million USD |
2008Q3 | 32.0 million USD | 758.0 million USD |
2008Q2 | 13.0 million USD | 676.0 million USD |
2008Q1 | -3.0 million USD | 626.0 million USD |
2007Q4 | 24.0 million USD | 600.0 million USD |
2007Q3 | 58.0 million USD | 753.0 million USD |
2007Q2 | 52.0 million USD | 683.0 million USD |
2007Q1 | 229.0 million USD | 625.0 million USD |
2006Q4 | 29.0 million USD | 653.0 million USD |
2006Q3 | 30.0 million USD | 676.0 million USD |
2006Q2 | 16.0 million USD | 684.0 million USD |
2006Q1 | 11.0 million USD | 585.0 million USD |
2005Q4 | 35.0 million USD | 668.0 million USD |
2005Q3 | 17.0 million USD | 628.0 million USD |
2005Q2 | 26.4 million USD | 643.1 million USD |
2005Q1 | 13.1 million USD | 577.0 million USD |
2004Q4 | 55.0 million USD | 1.9 billion USD |
2004Q3 | 27.8 million USD | 611.3 million USD |
2004Q2 | -15.0 million USD | 133.0 million USD |
2004Q1 | 22.0 million USD | 540.0 million USD |
2003Q4 | 141.0 million USD | 1.9 billion USD |
2003Q3 | 44.0 million USD | 629.0 million USD |
2003Q2 | 12.0 million USD | 120.0 million USD |
2003Q1 | 35.0 million USD | 528.0 million USD |
2002Q4 | 81.0 million USD | 1.6 billion USD |
2002Q3 | 36.0 million USD | 571.0 million USD |
2002Q2 | 38.0 million USD | 607.0 million USD |
RGC Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -5.9 million USD | ? USD |
2022 | -7.4 million USD | ? USD |
2021 | -1.3 million USD | ? USD |
2020 | -812371 USD | ? USD |
2019 | -390990 USD | ? USD |
2018 | 112.3 million USD | 3.2 billion USD |
2017 | 170.4 million USD | 3.2 billion USD |
2016 | 153.4 million USD | 3.1 billion USD |
2015 | 105.6 million USD | 3.0 billion USD |
2014 | 157.7 million USD | 3.0 billion USD |
2013 | 144.8 million USD | 2.8 billion USD |
2012 | 40.3 million USD | 2.7 billion USD |
2011 | 77.6 million USD | 2.8 billion USD |
2010 | 95.5 million USD | 2.9 billion USD |
2009 | 72.0 million USD | 2.8 billion USD |
2008 | 363.0 million USD | 2.7 billion USD |
2007 | 86.0 million USD | 2.6 billion USD |
2006 | 91.0 million USD | 2.5 billion USD |
2005 | 82.0 million USD | 2.5 billion USD |
2004 | 185.0 million USD | 2.5 billion USD |
2003 | 117.0 million USD | 2.1 billion USD |
RGC
Price: 4.50USD
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.45 USD
P/E Ratio: -17.78
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 700
Ebitda: 521.8 millionMarket Capitalization: 45.5 million
Average Dividend Frequency: 4